Your session is about to expire
← Back to Search
DDP733 for Irritable Bowel Syndrome with Constipation
Study Summary
This trial will study whether DDP733 is safe and effective for treating IBS-c in women. IBS-c is a gastrointestinal disorder.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Find a Location
Who is running the clinical trial?
Media Library
- I have had recent issues or surgery related to my digestive system.I've had stomach pain or discomfort for at least 3 days a month in the last 3 months.I feel better after going to the bathroom.My stool's appearance has recently changed.I cannot stop or change my current medications that might affect the study.I have a condition that affects how food moves through my intestines.I am a woman aged between 18 and 65.My bowel movements have become more or less frequent recently.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are researcher still enrolling people in this experiment?
"Information available on clinicaltrials.gov suggests that this study is not looking for any more participants at the moment. This particular trial was first posted on October 1st, 2007 but the listing was last updated April 7th, 2008. There are 1547 other trials which are actively recruiting patients right now."
In how many different medical clinics is this clinical study being run today?
"To make things easier for those who enroll, the 69 sites participating in this trial are located near major cities such as Seattle, Sherwood and Tucson. Additionally, there are other locations around these areas."
Do you have to be a certain age to participate in this experiment?
"The age requirements to participate in this trial are that potential patients must be over 18 but under 65."
For which patient population is this clinical trial designed?
"This study is looking for 360 patients that have irritable bowel syndrome and fit the following criteria: they must be female, between 18-65 years old, have experienced a change in their stool frequency or appearance, and be willing to use a phone-in information system to complete daily diary assessments."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What site did they apply to?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger